Medicure (OTCMKTS:MCUJF) Posts Earnings Results

Medicure (OTCMKTS:MCUJF) announced its earnings results on Thursday. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.01, Zacks reports. Medicure had a negative return on equity of 42.01% and a negative net margin of 21.65%.The company had revenue of $5.79 million for the quarter, compared to analyst estimates of $3.63 million.

Medicure Stock Performance

Shares of MCUJF opened at $0.80 on Friday. The business’s 50 day moving average is $0.83 and its two-hundred day moving average is $0.84. Medicure has a 52-week low of $0.68 and a 52-week high of $0.97. The firm has a market cap of $8.39 million, a price-to-earnings ratio of -1.71 and a beta of 0.97. The company has a quick ratio of 0.77, a current ratio of 1.02 and a debt-to-equity ratio of 0.03.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.